Piper Sandler upgraded Bath & Body Works to Overweight from Neutral with a price target of $35, down from $38. The company’s business is “fairly well-insulated” from macro pressures relative to peers, with minimal outside the U.S. sourcing, a vertically integrated structure, and accessible price-points, the analyst tells investors in a research note. The firm says Bath & Body’s valuation is attractive with its discounts versus consumer peers at multi-year lows. This creates an attractive entry point, contends Piper. The firm adds that Bath & Body performed well in its latest survey of teens.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target lowered to $36 from $48 at Citi
- Softlines partially priced in China tariffs, not Vietnam, says Morgan Stanley
- Bath & Body Works files automatic mixed securities shelf
- Positive Outlook for Bath & Body Works Driven by Innovation and Strategic Growth Initiatives
- Bath & Body Works Reaffirms 2025 Financial Guidance
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue